Novel Drug Delivery System (NDDS) Market Global Analysis, Trends, Share, Size, Growth, Opportunity and Forecast 2018 - 2026
![]() |
Innovative approaches, technologies, formulations, and systems for transporting active pharmaceutical ingredients into the body to achieve the desired pharmacological effect are referred to as novel drug delivery systems. Nanoparticles, liposomes, nanoemulsion, nanogel, and microemulsion are some of the formulations used in NDDS. NDDS opens the door to more precise and targeted drug delivery.
The benefits provided by controlled-release drug delivery systems, such as lower treatment costs, fewer side effects, and improved therapeutic efficacy, are expected to drive growth in the global Novel Drug Delivery System Market. The increasing use of controlled-release drugs as a standard treatment for a variety of diseases, rising physician awareness and demand for advanced products, and increased prescription of controlled-release products are some of the key factors that are expected to drive market growth in the near future.
The presence of several in-vivo biological barriers that impact drug stability, absorption, and bioavailability is creating lucrative opportunities for the use of controlled-release drug delivery systems. The rapidly growing paediatric and geriatric populations are also driving the adoption of controlled-release drug delivery systems, owing to the high incidence of non-adherence to prescription drugs in these age groups.
Market Segmentation:
By route of administration type
- Injectable
- Oral
- Pulmonary
- Transdermal
- others
- Nanoparticles
- Liposomes
- Microspheres
- Monoclonal antibodies
- others
- Hospitals
- Medical research centers
- Cancer treatment centers
- others
Comments
Post a Comment